Newer research transforming 24-month treatment of MDR/XDR-TB TO 6 months. [PDF]
Jain N, Sharma D, Jain NK.
europepmc +1 more source
Outcomes in multidrug-resistant tuberculosis
openaire +3 more sources
Hearing Impairment Among Drug-Resistant Tuberculosis Patients in Rural Eastern Cape: A Retrospective Analysis of Audiometric Findings. [PDF]
Faye LM+4 more
europepmc +1 more source
Patients' acceptability, adherence and satisfaction on the modified shorter all-oral multidrug-resistant tuberculosis regimen: a two-phase cross-sectional study in Tanzania. [PDF]
Lalashowi J+14 more
europepmc +1 more source
Development and validation of a nomogram predicting multidrug-resistant tuberculosis risk in East China. [PDF]
He F+5 more
europepmc +1 more source
Tuberculosis Incidence and Outcomes Among Older New Yorkers. [PDF]
Kyaw NTT+5 more
europepmc +1 more source
Non-inferiority stepped wedge cluster randomized controlled trial on all-oral shorter regimens for rifampicin resistant/multidrug-resistant TB in Pakistan - a study protocol. [PDF]
Khan N+9 more
europepmc +1 more source
Related searches:
Management of Multidrug-Resistant Tuberculosis
Seminars in Respiratory and Critical Care Medicine, 2013AbstractDrug-resistant strains of Mycobacterium tuberculosis pose a major threat to global tuberculosis control. Despite the availability of curative antituberculosis therapy for nearly half a century, inappropriate and inadequate treatment of tuberculosis, as well as unchecked transmission of M.
Charles L. Daley, Jose A. Caminero
openaire +4 more sources